Could an allergy drug boost brain power in williams syndrome?
NCT ID NCT06087757
First seen Apr 04, 2026 · Last updated May 09, 2026 · Updated 6 times
Summary
This study tests whether clemastine, an allergy medicine, can improve thinking, movement, and daily skills in people with Williams syndrome. About 30 people aged 6 to 30 will take either the drug or a placebo for several weeks. Researchers will measure changes in IQ, memory, and motor abilities to see if the treatment is safe and helpful.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WILLIAMS SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Child and Adolescent Psychiatry Unit, Sheba Medical Center
Ramat Gan, Israel
-
Tel Aviv University
Tel Aviv, Israel
Conditions
Explore the condition pages connected to this study.